• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Tracking cancer’s signaling pathways

Bioengineer by Bioengineer
May 24, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Malignant melanoma is one of the most common and dangerous types of cancer. Researchers at Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) investigated how and why brown pigmented moles turn into malignant melanoma using innovative robot technology. The insights gained can simplify methods of diagnosis in the future; furthermore, they suggest that certain cosmetic products and creams should be avoided.

Until now, researchers only knew which genetic mutations were responsible for triggering the transformation of benign pigmented moles into malignant tumours. But little was known about what happens to proteins and signalling pathways when a malignant melanoma develops. The research group led by Prof. Dr. Andreas Baur at FAU's Translational Research Center (TRC) have now discovered that the ADAM10 signalling pathway is activated during the transformation. This pathway is a protein chain that passes the signal from one protein to the next, similar to chasing LED lights. This protein chain is normally inactive in healthy skin and is only activated in an immune response. It is known for its role in psoriasis, rosacea (a type of facial rash) and inflammation, i.e. when the immune system is activated but is also key in the development of malignant melanoma.

FAU researchers were able to demonstrate the significance of the ADAM10 signalling pathway with regard to the development of melanoma using a new kind of robot. The robot makes it possible to investigate development processes in skin samples at a cellular level. It uses anti-bodies marked with fluorochrome to stain tissue cell proteins. A camera takes a photo of the tissue samples. The fluorochrome is then bleached to destroy it, rendering the anti-body invisible. The robot applies another anti-body and the process is repeated. This method produces a sequence of different images of the same tissue sample that can be superimposed to reveal which proteins are active in which cells and where. Prior to the new technology, only one to four markers could be stained; the robot can now stain more than 100 proteins.

The insights gained will enable a better diagnosis of malignant melanoma in the future. 'This is especially important in borderline cases where it is difficult to make a clear decision whether a tumour is benign or malignant', says Baur. In the long term, the findings will enable a simplified, automated diagnosis of malignant melanoma using staining robots. Additionally, the research suggests that cosmetic products and sun screen containing aluminium should be avoided, as aluminium ions can non-specifically activate the ADAM10 signalling pathway that leads to melanoma.

The research results were published as a feature article in a special cancer edition of Science Signaling 10 in March 2017: "Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytes".

###

Media Contact

FAU Press Office
[email protected]
49-913-185-70229
@FAU_Germany

http://www.uni-erlangen.de

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Optimizing Biogas from Phragmites: Grinding, Season, Co-Digestion

September 6, 2025
Tofu Whey Aquaforte Reduces Inflammation in Skin Cells

Tofu Whey Aquaforte Reduces Inflammation in Skin Cells

September 6, 2025

Overcoming Challenges in Pressure Injury Management Guidelines

September 6, 2025

Sexual Dimorphism in UGT Deficiency: New Insights Revealed

September 6, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Optimizing Biogas from Phragmites: Grinding, Season, Co-Digestion

Tofu Whey Aquaforte Reduces Inflammation in Skin Cells

Overcoming Challenges in Pressure Injury Management Guidelines

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.